Blood tests revealed raised transaminases (AST 1499 IU/L, ALT to 1085 IU/L), hyperbilirubinemia (total bilirubin 7.3 mg/dl, unconjugated bilirubin 6.9 mg/dl) and coagulopathy (INR 1.68) (Fig. 1). This evidence concerns the gene GPT and Hyperbilirubinemia.